AMERICAN JOURNAL OF GASTROENTEROLOGY, cilt.105, ss.1762-1769, 2010 (SCI İndekslerine Giren Dergi)
OBJECTIVES: Hepatitis B e antigen (HBeAg)-negative chronic hepatitis B patients are at high risk of treatment relapse after any antiviral therapy. Combining peginterferon alpha-2a with ribavirin might improve sustained response rates.